Terug
12
Ook genoteerd als
SHCAY
OTC
Dagbereik
€ 4,40
€ 4,40
52-Weeksbereik
€ 4,40
€ 6,45
Volume
100
50D / 200D Gem.
€ 4,73
/
€ 5,46
Vorige Slotkoers
€ 4,40
Koershistorie
Financiële Trends
Sectorvergelijking
vs Technology sector mediaan (620 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 0,1 | 12,6 |
| P/B | 0,0 | 3,0 |
| ROE % | 24,2 | 8,9 |
| Net Margin % | 1,7 | 5,6 |
| Rev Growth 5Y % | -2,9 | 9,2 |
| D/E | 3,4 | 0,3 |
Belangrijkste Punten
Revenue declined -2,86% annually over 5 years
ROE of 24,24% indicates high profitability
Debt/Equity of 3,37 — high leverage
Negative free cash flow of -28,39B
P/E of 0,08 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 4,11%
Groei
Revenue Growth (5Y)
-2,86%
Revenue (1Y)-6,97%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
24,24%
ROIC3,03%
Net Margin1,67%
Op. Margin1,27%
Veiligheid
Debt / Equity
3,37
Current Ratio1,29
Interest Coverage2,66
Waardering
P/E Ratio
0,08
P/B Ratio0,02
EV/EBITDA10,30
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -6,97% | Revenue Growth (3Y) | -7,93% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -2,86% | Earnings Growth (5Y) | -9,27% |
| Profitability | |||
| Revenue (TTM) | 2,16T | Net Income (TTM) | 36,10B |
| ROE | 24,24% | ROA | 2,48% |
| Gross Margin | 18,78% | Operating Margin | 1,27% |
| Net Margin | 1,67% | Free Cash Flow (TTM) | -28,39B |
| ROIC | 3,03% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 3,37 | Current Ratio | 1,29 |
| Interest Coverage | 2,66 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 0,08 | P/B Ratio | 0,02 |
| P/S Ratio | 0,00 | PEG Ratio | -0,14 |
| EV/EBITDA | 10,30 | Dividend Yield | 0,00% |
| Market Cap | 2,86B | Enterprise Value | 281,50B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,16T | 2,32T | 2,55T | 2,50T | 2,43T |
| Net Income | 36,10B | -149,98B | -260,84B | 73,99B | 53,26B |
| EPS (Diluted) | 55,59 | -230,99 | -407,31 | 121,14 | 87,20 |
| Gross Profit | 405,71B | 347,89B | 330,83B | 431,72B | 421,32B |
| Operating Income | 27,34B | -20,34B | -25,72B | 84,72B | 83,11B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,45T | 1,59T | 1,77T | 1,96T | 1,93T |
| Total Liabilities | 1,29T | 1,43T | 1,55T | 1,49T | 1,56T |
| Shareholders' Equity | 154,65B | 143,18B | 208,74B | 454,57B | 350,65B |
| Total Debt | 521,35B | 589,86B | 725,59B | 626,57B | 724,92B |
| Cash & Equivalents | 242,70B | 227,13B | 262,06B | 287,36B | 341,92B |
| Current Assets | 979,82B | 990,23B | 1,09T | 1,23T | 1,19T |
| Current Liabilities | 756,92B | 856,36B | 882,56B | 808,20B | 885,58B |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#509 of 658
Recente Activiteit
Ingestapt
Contrarian Investing (David Dreman)
Mar 24, 2026